You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Second‐generation antipsychotics for major depressive disorder and dysthymia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2010
|
| DOI | 10.1002/14651858.cd008121.pub2 |
| Pubmed ID | |
| Authors |
Katja Komossa, Anna M Depping, Andrea Gaudchau, Werner Kissling, Stefan Leucht |
| Abstract |
Major depressive disorder (MDD) is a common condition with a lifetime prevalence of 15% to 18%, which leads to considerable suffering and disability. Some antipsychotics have been reported to induce remission in major depression, when added to an antidepressant. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 20% |
| Canada | 1 | 20% |
| Unknown | 3 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 60% |
| Science communicators (journalists, bloggers, editors) | 1 | 20% |
| Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 309 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 2 | <1% |
| Netherlands | 1 | <1% |
| South Africa | 1 | <1% |
| United Kingdom | 1 | <1% |
| Canada | 1 | <1% |
| Japan | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 301 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 49 | 16% |
| Student > Master | 41 | 13% |
| Student > Doctoral Student | 28 | 9% |
| Student > Ph. D. Student | 27 | 9% |
| Other | 26 | 8% |
| Other | 77 | 25% |
| Unknown | 61 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 123 | 40% |
| Psychology | 32 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 24 | 8% |
| Nursing and Health Professions | 15 | 5% |
| Agricultural and Biological Sciences | 8 | 3% |
| Other | 33 | 11% |
| Unknown | 74 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 February 2024.
All research outputs
#1,316,333
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#2,786
of 11,499 outputs
Outputs of similar age
#6,343
of 191,497 outputs
Outputs of similar age from Cochrane database of systematic reviews
#14
of 112 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,497 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 112 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.